<DOC>
	<DOCNO>NCT01153243</DOCNO>
	<brief_summary>Recent clinical trial non diabetic show vitamin D supplementation markedly reduce serum level C-reactive protein ( CRP ) , interleukin-6 , tissue matrix metallo-proteinases . Our study objective evaluate administration vitamin D African Americans hypovitaminosis D DM Type 2 decrease serum level inflammatory/thrombotic marker CRP : Highly Sensitive C Reactive Protein .</brief_summary>
	<brief_title>Vitamin D Inflammatory Markers Cardiovascular Disease African Americans With Type 2 Diabetes</brief_title>
	<detailed_description>Other question study : In diabetic African American patient , 1 . Prevalence vitamin D deficiency ? 2 . Correlation/relationship vitamin D level , Calcium level , parathyroid hormone ( PTH ) Inflammatory marker Setting : All visit take place Fantus Diabetes Clinic .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>African Americans DM type 2 symptomatic vitamin D deficiency hypocalcemia hypercalcemia malabsorption liver disease patient creatinine &gt; 1.5 . ( CKD &gt; /= 3 ) pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>inflammatory marker</keyword>
</DOC>